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Abstract: Endobronchial ultrasonography (EBUS) has emerged as a
new diagnostic tool that allows the bronchoscopist to see beyond the
airway. The radial probe EBUS was first introduced to evaluate the
airway structure, which has been shown to be useful for identifying
the extent of tumor invasion in the central airway. With advance in
technology, smaller radial probes are now available that are capable
of visualizing peripheral lung nodules. EBUS is also used as a tool
to assist in a biopsy in respiratory diseases. The radial probe
EBUS–guided transbronchial needle aspiration (TBNA) increases
the yield of TBNA of mediastinal processes. By the use of the
ultra-miniature probe EBUS along with the guide sheath, peripheral
lung lesions can be accessed without the exposure to radiation.
However, it is still not a real-time procedure with target visualiza-
tion. The newest development is the convex probe EBUS (CP-
EBUS) with a curvilinear electronic transducer on the tip of a
flexible bronchovideoscope. CP-EBUS allows real-time EBUS-
guided TBNA. Although the main indication for EBUS-TBNA is
lymph node staging, it can also be used for diagnosis of intrapul-
monary tumors, of unknown hilar and/or mediastinal lymphadenop-
athy, and of mediastinal tumors. To date, there are no reports of
complications related to EBUS-guided TBNA. It is a novel approach
that has a good diagnostic yield with excellent potential in assisting
safe and accurate diagnostic interventional bronchoscopy. The aim
of this review is to highlight the current status of the different EBUS
techniques available and to discuss the future direction of EBUS.
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bronchial needle aspiration.
(J Thorac Oncol. 2007;2: 970–979)
Endobronchial ultrasonography (EBUS) is a new tool thatallows the bronchoscopist to see beyond the airway. Al-
though bronchoscopic observation only allows visualization
of the internal surface of the airway, EBUS allows analysis of
the airway structure as well as processes surrounding the
airway. After solving technical difficulties for the application
of ultrasonography in bronchoscopic practice, the radial
probe EBUS was commercially introduced in the early
1990s.1 EBUS is a new diagnostic tool with great potential
for the evaluation of the airway and for the diagnosis of lung
cancer and lung cancer staging.
There are two types of EBUS available for clinical use:
the radial probe EBUS and the convex probe EBUS. The
miniaturized 20-MHz radial probe (UM-BS20-26R, Olym-
pus, Tokyo, Japan) was first introduced for optimal imaging
of the bronchial wall. This enables the evaluation of tumor
infiltration to the airways, which is useful for the evaluation
of early lung cancer and extensive disease.2–4 The radial
probe EBUS also enables visualization of mediastinal and
hilar lymph nodes. Radial EBUS guidance has been shown to
increase the yield of transbronchial needle aspiration (TBNA)
for lymph node staging of lung cancer.5,6 Recently, an even
smaller ultra-miniature radial probe (UM-S20-20R, Olym-
pus), which can be introduced into the channel of the bron-
choscope like any other forceps, has been used to detect
peripheral intrapulmonary nodules.7 Studies have shown that
EBUS can replace fluoroscopy for guiding biopsy procedures
on peripheral intrapulmonary lesions by the application of
sheath catheters.8–11 However, due to the nature of the probe,
it is still not a real-time procedure with target visualization.
Although the radial probe EBUS is a useful tool that
can broaden the practice of interventional pulmonology, it is
still underused. A new endoscope with a built-in linear probe
ultrasonography on the tip was developed in collaboration
with Olympus Corporation. This new convex probe EBUS
(CP-EBUS) enables real-time EBUS-guided TBNA (EBUS-
TBNA). The linear ultrasound images are easier to under-
stand. After preliminary studies showing the efficacy of
CP-EBUS in surgical lung specimens,12 we first reported the
clinical use of CP-EBUS for the assessment of mediastinal
and hilar lymph nodes.13 The growing number of publications
concerning the use of EBUS-TBNA for the evaluation of the
mediastinal lymph nodes indicates the effectiveness of the
new device.12–22
This article reviews the current status of different tech-
niques of EBUS available in the assessment of respiratory
diseases. In particular, the utility of EBUS for lung cancer
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diagnosis and lymph node staging is reviewed. In addition,
the future directions of EBUS are discussed.
DIFFERENT TYPES OF EBUS
Radial Probe EBUS
Two basic types of EBUS radial probes are available. The
miniaturized 20-MHz radial probe EBUS (UM-BS20-26R,
Olympus) fitted with a catheter that carries a water-inflatable
balloon at the tip (Figure 1A and B) is used for the assessment
of central airways. The balloon optimizes the contact between
the probe and the bronchial wall and allows visualization of
detailed images of the bronchial wall structure and surrounding
structures.2 The structure of the cartilaginous portion of the
central bronchial wall has been described as a five- or seven-
layer structure by different authors.2,3 The miniaturized ultra-
sound probe can be inserted through a 2.8-mm working channel
(Figure 1C). The probe rotates 360 degrees to obtain detailed
images of the surrounding structures and the bronchial wall
structure. The 20-MHz EBUS has a resolution of1 mm and a
penetration of 5 cm. The probe can be used from the trachea to
the subsegmental bronchus.
The ultra-miniature radial probe (UM-S20-20R, Olym-
pus) was developed for the detection of peripheral lung
nodules. It is also a 20-MHz radial probe, which has an
external diameter of 1.4 mm (Figure 1D). The probe is placed
into a guide sheath (GS) and the GS-covered probe can be
inserted into a 2.0-mm working channel of a regular flexible
bronchoscope (Figure 1E). The GS-covered probe is ad-
vanced to the peripheral lesion to obtain an EBUS image.
After localizing the lesion, the probe is removed, leaving the
GS in place. A biopsy forceps and/or a bronchial brush are
then introduced into the GS to perform pathologic and cyto-
logic examination.
CP-EBUS
The CP-EBUS is integrated with a convex transducer with
a frequency of 7.5 MHz at the tip of a flexible bronchoscope
(XBF-UC260F-OL8, Olympus), which scans parallel to the
insertion direction of the bronchoscope (Figure 2). The outer
diameter of the insertion tube of the flexible bronchoscope is 6.7
mm and that of the tip is 6.9 mm. The angle of view is 90
degrees, and the direction of view is 30 degrees forward oblique.
Ultrasound images can be obtained by directly contacting the
probe or by attaching a balloon on the tip and inflating with
saline (Figure 2B). The ultrasound image is processed in a
dedicated ultrasound scanner (EU-C2000, Olympus) and is vi-
sualized along with the conventional bronchoscopy image on the
same monitor (Figure 3). The ultrasound images can be frozen,
and the size of lesions can be measured in two dimensions by the
placement of cursors. This system also has the Doppler mode.
The dedicated 22-gauge needle passed through the
2.0-mm instrument channel allows EBUS-TBNA (Figure
2B). The needle is also equipped with an internal sheath that
is withdrawn after passing the bronchial wall, avoiding con-
tamination during TBNA. The needle can be visualized
through the optics and on the ultrasound image.
Because the endobronchial images obtained by the
CP-EBUS scope are not as clear as those obtained with the
conventional flexible bronchovideoscope, the authors prefer
to examine the tracheobronchial tree using the conventional
scope. All procedures can be performed under local anesthe-
sia and conscious sedation (midazolam). Nasal insertion may
be difficult due to the probe on tip of the scope. After
identifying the lesion of interest with the CP-EBUS, the
surrounding structures are also visualized with the use of the
Doppler mode to confirm blood vessels. The dedicated
TBNA needle is inserted through the working channel of the
FIGURE 1. (A) A 20-MHz minia-
turized radial probe (UM-BS20-
26R). (B) Balloon sheath (MAJ-
643R). (C) A 20-MHz miniature
radial probe (UM-BS20-26R) with
the balloon sheath (MAJ-643R) on
the tip inflated with water, inserted
through a 2.8-mm working chan-
nel of a flexible bronchoscope. (D)
A 20-MHz ultra-miniature radial
probe (UM-S20-20R) with a diame-
ter of 1.4 mm, which is used for
peripheral intrapulmonary lesions.
(E) The probe is placed into a
guide sheath and the guide
sheath–covered probe can be in-
serted into a 2.0-mm working
channel of a flexible bronchoscope.
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bronchoscope, and the lesion is punctured under direct EBUS
guidance. The aspirated material is smeared onto glass slides.
Smears are air dried as well as fixed in 95% alcohol. Fur-
thermore, Papanicolaou staining and light microscopy are
performed by a cytopathologist. Histologic specimens ob-
tained are fixed in formalin before being sent to the pathology
department.
Indications for EBUS-TBNA are assessment of medi-
astinal and hilar lymph nodes and diagnosis of lung tumors
and mediastinal tumors. All the mediastinal lymph nodes
except for the subaortic and paraesophageal lymph nodes
(levels 5, 6, 8, and 9) are accessible by CP-EBUS. Because
the outer diameter of the tip of the CP-EBUS is 6.9 mm, hilar
lymph node levels 10 and 11 are approachable. However, part
of level 12 is not accessible.
EBUS FOR EVALUATION OF THE CENTRAL
AIRWAY
Radial probe EBUS was first developed for the evalu-
ation of the central airway. It has been used for the manage-
ment of patients with early lung cancer. In particular, prema-
lignant lesions or small intrabronchial radiographically
invisible tumors detected accidentally or by screening in
high-risk patients. In these cases, the treatment strategy de-
pends on the extent of tumor invasion within the different
layers of the bronchial wall. Conventional radiographic im-
aging alone is not capable of distinguishing the tumor extent.
In contrast, radial probe EBUS can detect the alterations of
the multilayer structure of the bronchial wall for such small
tumors (Figure 4). A comparison of ultrasonograms and the
histologic findings in 24 lung cancer cases revealed that the
depth of tumor invasion was accurate in 23 lesions using
EBUS (95.8%).2 A smaller study in a series of 15 patients
showed a high diagnostic yield of 93% for predicting tumor
invasion into the tracheobronchial wall.23 EBUS has also
been shown to improve the specificity (from 50% to 90%) for
predicting malignancy in small autofluorescence-positive le-
sions that were negative in white light bronchoscopy.24
Photodynamic therapy is one of the best modalities for
early-stage lung cancer treatment as long as it is not an
invasive disease. Thus, confirmation of the extent of tumor
invasion becomes the most important factor before treatment.
A very interesting study looked at 18 biopsy-proven early-
stage squamous cell carcinomas for which EBUS was per-
formed to evaluate tumor extent.25 Nine lesions were diag-
nosed as intracartilaginous by EBUS, and photodynamic
therapy was subsequently performed. The other nine patients
had extracartilaginous tumors not detected by computed to-
mography (CT) and were considered candidates for other
therapies. Using EBUS, a 100% complete remission rate was
achieved in the endoluminal-treated group. At a mean fol-
low-up of 32 months, none of the patients had a recurrence.
Other than the use in early-stage lung cancer, EBUS
has been demonstrated to be useful for the evaluation of
advanced lung cancer. Preoperative assessment of tumor
spread in centrally located lung cancer is essential for tumor
resectability. One trial showed that EBUS, in contrast to chest
CT, was highly accurate in evaluating the question of airway
FIGURE 3. The dedicated ultrasound scanner (EU-C2000,
Olympus). The ultrasound images can be frozen, and the
size of lesions can be measured in two dimensions by the
placement of cursors.
FIGURE 2. (A) Tip of the ultrasound puncture broncho-
scope (CP-EBUS, Olympus XBF- UC260F-OL8) with the linear
curved array ultrasonic transducer. (B) The balloon attached
to the tip of the bronchoscope is inflated with normal saline
and a dedicated 22-gauge transbronchial needle aspiration
needle is inserted through the working channel to perform
EBUS-TBNA.
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involvement by central intrathoracic tumors.4 In 105 patients,
the ability of chest CT and EBUS to distinguish between
compression and infiltration was measured against the histo-
logic result. The specificity, sensitivity, and accuracy of
EBUS were 100%, 89%, and 94%, respectively. In contrast,
CT was far inferior, with a specificity of 28%, a sensitivity of
75%, and an accuracy of 51%. EBUS served as a more
accurate device compared with conventional imaging for the
prediction of T4 disease in lung cancer.
Other than lung cancer, EBUS has been shown to be
useful in the evaluation of airway invasion in esophageal
cancer and thyroid cancer.26 The accuracy of EBUS was
significantly greater than that of CT and magnetic resonance
imaging for the assessment of airway invasion. EBUS has
been used to evaluate airway anastomosis in lung transplant
recipients. A quantitative assessment of bronchial mural
structures in lung transplant recipients showed that EBUS can
discriminate different layers of the bronchi in humans and to
measure the thickness of these layers in a reproducible
fashion. Therefore, EBUS may be used to investigate and
quantify inflammatory alterations of bronchial wall structures
in vivo.27
EBUS FOR PERIPHERAL INTRAPULMONARY
LESIONS
Transbronchial biopsy (TBB) is often performed for
the diagnosis of peripheral intrapulmonary lesions. Al-
though the complication rate is generally low, there is radia-
tion exposure and the diagnostic yield varies widely.28,29 For
lesions that are too small to visualize by fluoroscopy, CT guidance
has been reported to increase the yield of TBB.30 Percutaneous
needle aspiration cytology is performed with a high yield, but
there is a high occurrence rate of pneumothorax.31
EBUS can be used to assist TBB of peripheral
intrapulmonary lesions. Because the air content of the lung
parenchyma completely reflects the ultrasound signal, pul-
monary masses can be precisely located by EBUS. Pulmo-
nary lesions have a hypoechoic texture and a sharply
defined border due to strong reflective interface between
the aerated lung and the lesion. Focusing on the internal
structure of the peripheral lesions, a classification system
for distinguishing benign from malignant lesions has been
reported.7 Moreover, EBUS-guided TBB of peripheral
pulmonary lesions has been shown to yield a similar
success rate as fluoroscopy guidance.32,33 A large-scale,
prospective, randomized study to compare EBUS-guided
TBB with TBB in patients with lesions 3 cm has been
performed with good results.34 In lesions 3 cm, there
were no significant differences in the diagnostic ability
between the two procedures. However, in lesions 3 cm
and 2 cm, a considerable decrease in TBB sensitivity
(31% and 23%) was seen, whereas EBUS-guided TBB
maintained its sensitivity (75% and 71%) (p  0.0002 and
p  0.001, respectively).
More recently, studies have shown the efficacy of a
new devise, the GS, for sampling of peripheral lesions to
increase the diagnostic yield of TBB under EBUS guid-
ance.8–11 A miniature probe introduced into the GS is
inserted into a working channel of a fiberoptic broncho-
scope. The GS-covered probe is advanced to the peripheral
lesion to obtain an EBUS image. After localizing the
lesion, the probe is removed, leaving the GS in place. A
biopsy forceps and a bronchial brush are introduced into
the GS to perform pathologic and cytologic examinations.
Surprisingly, the diagnostic yield of this new technique
was not affected by the tumor size, demonstrating the
efficacy of EBUS-GS even in lesions 10 mm in diame-
ter.8 It is even useful for TBB of fluoroscopically invisible
solitary pulmonary nodules.11 The problem with this tech-
nique is the complexity of the procedure.
LYMPH NODE STAGING IN LUNG CANCER
Invasive and Noninvasive Staging Modalities
During the staging process of lung cancer, accurate
lymph node staging is one of the important factors that affect
patient outcome. Conventional imaging methods available for
the evaluation of the mediastinum such as CT are inaccurate
in the diagnosis of mediastinal lymph node metastasis.35
Positron emission tomography (PET) has been reported to
increase the diagnostic yield.36 However, imaging alone is
inaccurate. Therefore, tissue confirmation of suspected ma-
lignant lymphadenopathy is required, especially before sur-
gical resection. The different methods available for obtaining
pathology specimens from the mediastinal lymph nodes in-
cludes mediastinoscopy, conventional TBNA, EBUS-guided
FIGURE 4. Endobronchial image
(A) and radial probe EBUS scan (B)
obtained in a 67-year-old patient
with a tracheal tumor. (A) Endo-
bronchial image demonstrates a
superficial tracheal tumor (arrow).
(B) Radial EBUS image showed the
six distinct layers. There was no
invasion to the cartilage layer (ar-
row). Brachytherapy was performed
with good results.
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TBNA using a radial probe, CT fluoroscopy-guided TBNA,
and endoscopic ultrasonography–guided fine needle aspira-
tion (EUS-FNA) (Table 1).5,6,37–42 However each of these
methods has its limitations.
Conventional bronchoscopic TBNA would be the pre-
ferred method for patients with radiographic evidence of
enlarged mediastinal lymph nodes that are adjacent to the
airways because bronchoscopy is usually performed in lung
cancer patients and assessment for endobronchial lesions can
be performed during the same procedure. However, conven-
tional TBNA is a blind procedure preventing target visual-
ization and therefore the yield for TBNA varies widely.39–41
To overcome these problems, EBUS has been used to in-
crease the yield of TBNA.
Before the availability of the CP-EBUS, the radial
probe EBUS was used for TBNA guidance of mediastinal
lymph nodes.5,6 Although a high diagnostic yield has been
reported, it is still not a real-time procedure with target
visualization. The introduction of the CP-EBUS has allowed
real-time TBNA of mediastinal and hilar lymph nodes (Fig-
ure 5).
EBUS-TBNA for Lymph Node Staging
The first article to report the diagnostic yield of EBUS-
TBNA in a prospective study for lymph node staging of lung
cancer not only showed the high yield, but also the impact of
this procedure on patient management.15 CP-EBUS can ac-
cess all the mediastinal lymph nodes except for the subaortic
and paraesophageal lymph nodes (levels 5, 6, 8, and 9). Hilar
lymph nodes (levels 10 and 11) are also approachable. In 105
patients, EBUS-TBNA was successfully performed to obtain
samples from 163 lymph nodes. With respect to the correct
prediction of lymph node stage, EBUS-TBNA had a diag-
nostic accuracy rate of 96.3%. In the 20 suspected lung
cancer cases, a mediastinal lymph node was used for tissue
diagnosis of malignancy and staging. In addition, as a result
of EBUS-TBNA, 29 mediastinoscopies, eight thoracotomies,
four thoracoscopies, and nine CT-guided percutaneous needle
biopsy were avoided. EBUS-TBNA spared invasive staging
procedures, which had a major impact on patient manage-
ment in lung cancer.
Additional reports have shown the use of EBUS-TBNA
in combination with EUS-FNA for the mediastinal lymph
node staging of lung cancer.17,18 EBUS has better access to
anterior and superior mediastinal lymph nodes, whereas EUS
has better access to posterior and inferior mediastinal lymph
nodes. Theoretically, the whole mediastinum is accessible by
combining EBUS and EUS.
TABLE 1. Comparison of Invasive Staging Modalities of the
Mediastinum
Method Accessible Nodal Stations
Standard mediastinoscopy Superior mediastinal, subcarinal
VATS Superior mediastinal (right),
subcarinal, aortic nodes





EUS-FNA Subaortic, inferior mediastinal,
subcarinal
EBUS, endobronchial ultrasonography; EUS-FNA, endoscopic ultrasonography–
guided fine-needle aspiration; EBUS-TBNA, endobronchial ultrasonography–guided
transbronchial needle aspiration; TBNA, transbronchial needle aspiration; VATS, video-
assisted thoracoscopic surgery.
FIGURE 5. Chest computed to-
mography (CT) (A), endobronchial
ultrasonography (EBUS) (B), and
pathology (C, D) performed in a
58-year-old patient with lung can-
cer of the right upper lobe. (A) A
CT scan demonstrates pretracheal
lymph node swelling (level 4R
lymph node). (B) EBUS demon-
strates level 4R lymph node (4R)
and SVC. The 22-gauge needle is
seen within the lymph node. (C)
EBUS-transbronchial needle aspira-
tion (TBNA) revealed adenocarci-
noma on cytology. (D) A histologic
specimen was also obtained by
EBUS-TBNA that revealed adenocar-
cinoma.
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Recently, a study comparing EBUS-TBNA, CT, and
PET for lymph node staging of lung cancer showed a high
yield using CP-EBUS.16 One hundred two potentially oper-
able patients with proven (n  96) or radiographically sus-
pected (n  6) lung cancer were included in the study. CT,
PET, and EBUS-TBNA were performed before surgery for
the evaluation of mediastinal and hilar lymph node metasta-
sis. EBUS-TBNA was successfully performed in all 102
patients (mean age, 67.8 years) from 147 mediastinal and 53
hilar lymph nodes. Sensitivity of CT, PET, and EBUS-TBNA
for the correct diagnosis of mediastinal and hilar lymph node
staging was 76.9%, 80.0%, and 92.3%, and specificity was
55.3%, 70.1%, and 100%, respectively. The diagnostic accu-
racies were 60.8%, 72.5%, and 98.0%. EBUS-TBNA was
proven to have a high sensitivity as well as specificity
compared with CT or PET, for mediastinal staging in patients
with potentially resectable lung cancer (Figure 6).
Comparison of EBUS-TBNA With
Mediastinoscopy
Currently the best means to assess lymph node involve-
ment is by direct lymph node sampling. The current gold
standard method to obtain such direct sampling is by medi-
astinoscopy. Mediastinoscopy has the ability to access sam-
ples of the paratracheal lymph node stations (levels 2R, 2L, 3,
4R, 4L) as well as the anterior subcarinal lymph node station
(level 7). Given the invasive and costly nature of a surgical
mediastinoscopy,43 there has been considerable interest
recently in the development of techniques that allow min-
imally invasive investigation and sampling of mediastinal
lymph nodes. EBUS-TBNA allows access to the paratra-
cheal lymph node stations (levels 2R, 2L, 3, 4R, 4L),
subcarinal lymph node (level 7), and the hilar lymph node
(levels 10, 11, and 12).
Although case series using EBUS-TBNA have reported
sensitivities of approximately 90% for detecting malignant
disease,12–20 there have been no studies directly comparing
mediastinoscopy and EBUS-TBNA. An ongoing study com-
paring the yield of mediastinoscopy and EBUS-TBNA for
mediastinal lymph node staging in patients with confirmed or
suspected lung cancer show promising results.44 All patients
underwent EBUS-TBNA followed by mediastinoscopy under
general anesthesia.
Of 45 patients enrolled in the study, the diagnostic
accuracy of EBUS-TBNA and mediastinoscopy for analysis
of each lymph node stations was 95.6% and 96.6%, respec-
tively. The sensitivity, specificity, and diagnostic accuracy
for the correct mediastinal lymph node staging for EBUS-
TBNA and mediastinoscopy were 76.9%, 100%, 90.9%, and
84.6%, 100%, and 93.9%, respectively. EBUS-TBNA was
uneventful, and there were no complications.44 These prelim-
inary results show that EBUS-TBNA may reduce the number
of mediastinoscopies needed for the staging of the mediasti-
FIGURE 6. Positron emission tomography–
computed tomography (PET-CT) (A, D), methi-
onine PET (B, E), and endobronchial ultra-
sonography (EBUS) (C, F) performed in a 72-
year-old patient with adenocarcinoma of the
lung. Lymph node levels 4R and 4L show accu-
mulation on both PET-CT and methionine PET.
EBUS-transbronchial needle aspiration of both
lymph node stations revealed normal lympho-
cytes. Surgical pathology proved N0 disease.
This is a representative case of false-positive
results obtained with CT and PET.
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num in non-small cell lung cancer. However, due to the
possibility of micrometastases, it is not clear that EBUS-
TBNA will completely replace mediastinoscopy for medias-
tinal staging.
OTHER POTENTIAL USES OF EBUS
EBUS-TBNA for Biopsy of Lung Tumors
The radial probe EBUS has been shown to be effective
in the evaluation of peripheral intrapulmonary nodules.7 In
addition, EBUS-guided biopsy of peripheral nodules using
the radial probe has been shown to have a good yield without
the exposure of radiation.8–11 However, these procedures are
not real-time biopsies.
Although EBUS-TBNA has been shown to be a useful
tool for the assessment and biopsy of mediastinal lymph
nodes,12–22 its role in the diagnosis of lung tumors has not
been identified. The reach of CP-EBUS depends on the size
of the bronchus. The outer diameter of the insertion tube of
the flexible bronchoscope is 6.7 mm and that of the tip is 6.9
mm. Usually the CP-EBUS can be inserted down to the lobar
bronchus. For lower lobes, it can be inserted into the basal
segmental bronchus. Lung tumors that are located adjacent to
the airway within the reach of CP-EBUS can be diagnosed
with EBUS-TBNA. We have experienced many cases in
which tumors are located adjacent to the bronchus, but
conventional bronchoscopic biopsy procedures produced in-
conclusive results. As shown in Figure 7, tumors not assess-
able by conventional bronchoscopy can easily be detected by
CP-EBUS, and a firm diagnosis can be obtained by EBUS-
TBNA. Lung tumors located in the apex adjacent to the
trachea usually difficult to diagnose by conventional bron-
choscopic biopsies can also be easily diagnosed by EBUS-
TBNA (Figure 8).
Diagnosis of Mediastinal Tumors
Mediastinal processes can be located precisely using
radial probe EBUS. This is performed by careful attention to
the relation to other mediastinal structures. Studies show that
EBUS is more suitable for the detection of infiltration of
mediastinal organs by tumor compared with conventional
radiographic imaging procedures.4 In case of compression of
airways, EBUS clearly differentiates between vascular abnor-
malities, fluid, and solid structures.45 Although EBUS has
been shown to be a valuable imaging modality for the
mediastinum, there are few reports concerning the actual
biopsy of mediastinal tumors under EBUS guidance.
With the introduction of CP-EBUS, real-time trans-
bronchial needle biopsy of the mediastinum is now possible.
We have used EBUS-TBNA of mediastinal tumors suspected
of malignancy in various patients (Figure 9). Mediastinal
processes diagnosed by EBUS-TBNA include bronchogenic
cyst, malignant lymphoma, thymic cancer, mediastinal goiter,
and chondrosarcoma.46,47 EBUS-TBNA for the diagnosis of
sarcoidosis has also been reported to have a very high yield.22
Compared with diagnosis of lymph node metastasis in lung
cancer patients, cytologic diagnosis of mediastinal tumors is
often more difficult. Histologic diagnosis is the preferred
choice. Although the current 22-gauge needle is capable of
obtaining a specimen suitable for histologic examination, a
larger needle that will allow us to sample better tissue is
needed.
FIGURE 7. Chest computed tomography (CT) (A), methio-
nine positron emission tomography (PET) (B), and endo-
bronchial ultrasonography (EBUS) (C) performed in an 84-
year-old patient with an intrapulmonary tumor suspected of
lung cancer. (A) CT scan demonstrates a small lesion along
the right lower lobe adjacent to the intermediate bronchus
(arrow). (B) Methionine PET showed an accumulation in the
lesion (arrows). (C) EBUS demonstrates the tumor 1.16 x
0.86 cm in diameter. EBUS-TBNA resulted in the diagnosis of
squamous cell carcinoma.
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FUTURE DIRECTIONS OF EBUS
The EBUS-TBNA scope has been shown by several
trials to have a high diagnostic yield for lymph node staging
of lung cancer. It is a minimally invasive procedure that
FIGURE 8. Chest computed tomography (CT) (A) and en-
dobronchial ultrasonography (EBUS) (B, C) performed in a
56-year-old patient with suspected lung cancer in the left
apical lesion. (A) CT scan demonstrates a tumor in the left
apex adjacent to the trachea (arrow). (B) EBUS demonstrates
the tumor 2.54 x 2.39 cm in diameter (markers at 1-cm in-
tervals). (C) EBUS-transbronchial needle aspiration was per-
formed. A 22-gauge needle is seen within the tumor. Cyto-
logic results demonstrated adenocarcinoma.
FIGURE 9. Chest computed tomography (CT) (A) and en-
dobronchial ultrasonography (EBUS) (B, C) performed in a
29-year-old patient with anterior mediastinal tumor sus-
pected of malignancy. (A) CT scan demonstrates an anterior
mediastinal tumor invading mediastinal structures (arrow).
(B) EBUS demonstrates the tumor in back of the brachioce-
phalic vein (BCV). (C) EBUS-transbronchial needle aspiration
resulted in the diagnosis of malignant lymphoma. A 22-
gauge needle is seen within the lymph node.
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spares many invasive procedures. To date, there have been no
reports of complications related to EBUS-TBNA. Although
the present data on EBUS-TBNA are promising, there is
always the possibility of false-negative results. To increase
the yield, a larger needle is necessary.
Conversely, the availability of multiple histologic cores
from the present 22-gauge needle raises the possibility of
looking at molecular diagnosis from EBUS-TBNA obtained
specimens.46 Our preliminary experience in lung cancer pa-
tients with N2 or N3 disease proven by EBUS-TBNA has
shown that DNA can be extracted from paraffin-embedded
samples obtained by EBUS-TBNA. The ability to perform
biological analysis using nonsurgical biopsy samples using
EBUS-TBNA will become very important for the future of
lung cancer treatment. EBUS-TBNA samples will possibly
provide other molecular biological information that will be
useful for the treatment of lung cancer.
Restaging of the mediastinum is another area of grow-
ing interest for the treatment strategy of lung cancer. In cases
of advanced lymph node stage lung cancer, induction che-
motherapy before surgical resection is an option. The current
restaging modalities either have a low diagnostic accuracy
(CT and PET) or are invasive. Mediastinoscopy is considered
the gold standard in staging the mediastinum. However,
repeat mediastinoscopy can be technically difficult and is
therefore not commonly performed. The ability to perform
multiple, repeat biopsies using EBUS-TBNA allows restag-
ing of the mediastinum after the introduction of chemother-
apy. Preliminary studies looking at the utility of EBUS-
TBNA for mediastinal restaging show promising results.
The reach of EBUS-TBNA and EUS-FNA for tissue
sampling of the mediastinum is complementary. EUS-FNA
can reach mediastinal lymph nodes not adjacent to the air-
ways and not accessible by EBUS-TBNA such as paraesoph-
ageal (level 8), pulmonary ligament (level 9), and subaortic
(level 5). Theoretically, by combining EBUS and EUS, a
complete and accurate evaluation of the whole mediastinum
is possible. Preliminary studies have shown a high diagnostic
yield for complete staging of the mediastinum.17,18,21 How-
ever, the transesophageal approach is usually unfamiliar to
most pulmonologists, and therefore a referral to a specialist is
needed, whereas EBUS-TBNA can be performed during
bronchoscopy. Further studies will need to prove the efficacy
of combining the two modalities in clinical practice.
Until now, the focus of using EBUS in respiratory
disease has been for diagnostic purposes. In the future, the
therapeutic use of EBUS will probably change the practice of
interventional pulmonology. Further advances in technology
will be important to meet these needs.
CONCLUSION
EBUS has emerged as a new tool to see beyond what
bronchoscopists are used to seeing. The radial probe EBUS
allows high-resolution imaging of the multilayer structures of
the bronchial wall as well as the evaluation of the surrounding
structures. The ultra-miniature radial probe can aid and increase
the diagnostic yield of peripheral intrapulmonary lesions.
EBUS-TBNA using the new ultrasonic puncture bronchoscope
allows real-time needle puncture of the mediastinum and the
hilum. It is a minimally invasive procedure that is safe with a
high diagnostic yield. The EBUS will be a valuable addition to
many bronchoscopic practices in pulmonary medicine in the
near future. Further prospective data describing the diagnostic
yield of EBUS-TBNA compared with conventional tools will be
needed to support the value of this new modality. However,
based on our current experience, we believe that the value of
CP-EBUS as a diagnostic tool for the staging of lung cancer as
well as mediastinal abnormalities will be established in the near
future.
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